Plus Therapeutics secures $15.0 million private placement for CNS cancer therapies

From GlobeNewswire: 2025-03-04 14:06:21

Plus Therapeutics, Inc. announced a private placement with gross proceeds of $15.0 million to advance CNS cancer therapies. The offering includes common units at $0.66 each, with pre-funded warrants exercisable immediately. The Company plans to use the funds for debt repayment, repurchasing warrants, and general corporate purposes. The transaction is expected to close on March 4, 2025. Plus Therapeutics is focused on developing targeted radiotherapeutics for CNS cancers, aiming to enhance patient outcomes. The Company operates in cancer clinical development hubs and has strategic partnerships for product development and manufacturing.



Read more at GlobeNewswire: Plus Therapeutics Secures Private Placement of